merit medical
-
Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal…
-
Merit Medical Launches basixSKY™ Inflation Device
Versatile analog device offers fast inflation and ease of use, streamlining patient care
-
Merit Medical Executive Leadership Team Update
Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.
-
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
New products broaden Merit’s leadership in embolotherapy.
-
First Patient Enrolled in Merit Medical’s MOTION Study
First Patient Enrolled in Merit Medical’s MOTION Study
-
Merit Medical Announces Process for Chief Executive Officer Succession Planning
Merit Medical Announces Process for Chief Executive Officer Succession Planning
-
Merit Medical Launches Expanded Maestro® Microcatheter Line
New multipurpose microcatheter length complements Merit’s radial-first legacy
-
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients
-
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global…
-
Merit Medical Reports Results for Quarter Ended September 30, 2022
Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.
-
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety
-
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
